TGF-β signaling and the fibrotic response
The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
The cause of fibrotic diseases, pathologies characterized by excessive production, deposition, and contraction of extracellular matrix, is unknown. To understand the molecular basis of fibrotic disease, it is essential to appreciate how matrix deposition is normally controlled and how this process is dysregulated in fibrogenesis. This review discusses the current state of knowledge concerning interactions among the profibrotic proteins transforming growth factor‐β (TGF‐β), connective tissue growth factor (CTGF, CCN2), and ED‐A fibronectin (ED‐A FN) and the antifibrotic proteins tumor necrosis factor‐α (TNF‐α) and γ‐interferon (IFN‐γ).—Leask, A., Abraham, D. J. TGF‐β signaling and the fibrotic response. FASEB J. 18, 816–827 (2004)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TGF-β is the critical mediator of pathological fibrosis after myocardial injury [64].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [64]
In the citing paper
“TNFα also suppresses the TGFβ stimulation of ECM production.62”
From The Innate Immune System in Acute and Chronic Wounds (2016) · cites this paper as [62]
Citations
Cites
1 retracted
RETRACTED: Deficient Smad7 expression: A putative molecular defect in scleroderma
Dong, C., Zhu, S., Wang, T., Yoon, W., Li, Z., Alvarez, R. J., ten Dijke, P., White, B., Wigley, F. M., & Goldschmidt-Clermont, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062010399 · Cited by 244 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultRetractedMassagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 2×
“Transcriptional responses induced by IFN- in most cells are mediated through the Jak-Stat pathway (146).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890 · cited 1×
“IFN- , a pleiotropic cytokine produced by T cells and NK cells, plays fundamental roles in innate and acquired immune responses (145).”
BackgroundYu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 2,203
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076 · cited 1×
“TSP-1 null mice demonstrate a partial phenotypic overlap with TGF- 1 null animals (30), and integrin 6 / are highly resistant to lung fibrosis induced by the profibrotic drug bleomycin (31).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundThe myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630 · cited 5×
“observed in lesions of fibrotic disease (2).”
BackgroundInfluentialMaking sense of latent TGFβ activation
Annes, J. P., Munger, J. S., & Rifkin, D. B. (2003) · Journal of Cell Science · doi:10.1242/jcs.00229 · Cited by 1,628
ECM and Cell Surface Proteolysis: Regulating Cellular Ecology
Werb, Z. (1997) · Cell · doi:10.1016/s0092-8674(00)80429-8 · Cited by 1,307
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272 · cited 1×
“This release assists in the attraction of neutrophils, macrophages, and fibroblasts, which in turn release more TGF- (71); accordingly, TGF- is consistently present in wound fluid throughout the repair process.”
BackgroundSignal Transduction by the TGF-β Superfamily
Attisano, L., & Wrana, J. L. (2002) · Science · doi:10.1126/science.1071809 · Cited by 1,268
Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo
Crawford, S. E., Stellmach, V., Murphy-Ullrich, J. E., Ribeiro, S. M. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998) · Cell · doi:10.1016/s0092-8674(00)81460-9 · Cited by 1,174
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras
Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999) · Genes & Development · doi:10.1101/gad.13.7.804 · Cited by 1,004 · cited 1×
“In epithelial cells, overexpression of constitutively active members of the ras/MEK/ERK cascade blocks nuclear accumulation of Smads; this may explain why transformed epithelial cells that show constitutive activation of ras are not responsive to TGF- (51).”
BackgroundAccelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-β
Mustoe, T. A., Pierce, G. F., Thomason, A., Gramates, P., Sporn, M. B., & Deuel, T. F. (1987) · Science · doi:10.1126/science.2442813 · Cited by 941 · cited 1×
“Supporting the notion that TGF- promotes fibrosis in vivo, treatment of fetal wounds with TGF- promotes wound closure and scarring (77, 78); TGF- induces excess matrix synthesis when injected subcutaneously in mice or into metal chambers implanted in the back of rats (78, 79).”
BackgroundHuman Smad3 and Smad4 Are Sequence-Specific Transcription Activators
Zawel, L., Le Dai, J., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., & Kern, S. E. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80061-1 · Cited by 939 · cited 1×
“Maximal affinity of recombinant Smad3 and Smad4 to DNA is observed with the 5 bp sequence CAGAC (40).”
BackgroundMice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911 · cited 1×
“After incisional wounding, animals lacking Smad3 show accelerated wound healing, reduced granulation tissue formation, increased epithelization, and reduced inflammation possibly due to an impaired chemotactic response (87) and resistance to cutaneous fibrosis caused by radiation injury (88).”
BackgroundSato, Y., & Rifkin, D. B. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.1.309 · Cited by 905 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundConnective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β
Abreu, J. G., Ketpura, N. I., Reversade, B., & De Robertis, E. M. (2002) · Nature Cell Biology · doi:10.1038/ncb826 · Cited by 902
Bradham, D. M., Igarashi, A., Potter, R. L., & Grotendorst, G. R. (1991) · The Journal of cell biology · doi:10.1083/jcb.114.6.1285 · Cited by 880 · cited 2×
“lial cells (6), is induced by TGF- and is considered a”
BackgroundSerini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., & Gabbiani, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.3.873 · Cited by 847 · cited 3×
“ED-A FN is expressed during embryogenesis and is de novo expressed during wound healing and fibrosis (2, 10, 68).”
BackgroundInhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway
Ulloa, L., Doody, J., & Massagué, J. (1999) · Nature · doi:10.1038/17826 · Cited by 812
Connective tissue growth factor: a mediator of TGF-β action on fibroblasts
Grotendorst, G. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00010-5 · Cited by 761
Ivkovic, S., Yoon, B. S., Popoff, S. N., Safadi, F. F., Libuda, D. E., Stephenson, R. C., Daluiski, A., & Lyons, K. M. (2003) · Development · doi:10.1242/dev.00505 · Cited by 713 · cited 1×
“Mice heterozygous for a deletion for the CTGF gene die immediately after birth due at least in part to defects on matrix organization and synthesis during osteogenesis, resulting in a major defect in the development of the skeletal component of the rib cage (114).”
BackgroundHocevar, B. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1345 · Cited by 675 · cited 3×
“ED-A FN is expressed during embryogenesis and is de novo expressed during wound healing and fibrosis (2, 10, 68).”
BackgroundSmad3 Mutant Mice Develop Metastatic Colorectal Cancer
Zhu, Y., Richardson, J. A., Parada, L. F., & Graff, J. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81730-4 · Cited by 671
Verrecchia, F., & Mauviel, A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01641.x · Cited by 666
Verrecchia, F., Chu, M.-L., & Mauviel, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100754200 · Cited by 664 · cited 1×
“Indeed, it has been shown that Smad 3 is essential for the induction of matrix, as induction of profibrotic genes such as type I collagen and connective tissue growth factor (CTGF) is prevented in fibroblasts lacking the Smad3 gene (64, 65).”
BackgroundThe CCN Family of Angiogenic Regulators: The Integrin Connection
Lau, L. F., & Lam, S. C.-T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4456 · Cited by 648
Overall, C. M., Wrana, J. L., & Sodek, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94267-5 · Cited by 636 · cited 8×
“Incisional rat wounds, if treated with anti-TGF- antibodies or antisense oligonucleotides, suppress ECM synthesis and scarring (80, 81).”
BackgroundInfluentialTransforming growth factor βs and wound healing
O'Kane, S., & Ferguson, M. W. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00120-3 · Cited by 634
Duncan, M. R., Frazier, K. S., Abramson, S., Williams, S., Klapper, H., Huang, X., & Grotendorst, G. R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1774 · Cited by 631
Bork, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80155-n · Cited by 627
Bone Morphogenetic Protein and Bone Morphogenetic Protein Gene Family in Bone Formation and Repair
Wozney, J. M., & Rosen, V. (1998) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199801000-00006 · Cited by 611 · cited 1×
“BMPs, originally identified as cytokines that induce bone and cartilage tissues in vivo (17), induce ventral mesoderm during early embryogenesis.”
BackgroundSmad2 role in mesoderm formation, left–right patterning and craniofacial development
Nomura, M., & Li, E. (1998) · Nature · doi:10.1038/31693 · Cited by 599 · cited 1×
“ogenesis (44) whereas mice homozygous for a deletion”
BackgroundExpression of connective tissue growth factor in human renal fibrosis
Ito, Y., Aten, J., Bende, R. J., Oemar, B. S., Rabelink, T. J., Weening, J. J., & Goldschmeding, R. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00820.x · Cited by 562 · cited 1×
“In contrast to the situation in normal fibroblasts, CTGF is constitutively overexpressed in dermal fibrotic lesions such as in scleroderma (95, 97, 98), liver (99), renal (100, 101), lung (102), and pancreatic fibrosis (103).”
Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.5.1137 · Cited by 498
Breuss, J. M., Gallo, J., DeLisser, H. M., Klimanskaya, I. V., Folkesson, H. G., Pittet, J. F., Nishimura, S. L., Aldape, K., Landers, D. V., Carpenter, W., et al. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.6.2241 · Cited by 487
Connective Tissue Growth Factor: What's in a Name?
Moussad, E. E.-D. A., & Brigstock, D. R. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3059 · Cited by 470
Mori, T., Kawara, S., Shinozaki, M., Hayashi, N., Kakinuma, T., Igarashi, A., Takigawa, M., Nakanishi, T., & Takehara, K. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199910)181:1<153::aid-jcp16>3.0.co;2-k · Cited by 468
Schultz-Cherry, S. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.923 · Cited by 468 · cited 1×
“For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
BackgroundA mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA.
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · PubMed · Cited by 461
Babic, A. M., Chen, C.-C., & Lau, L. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2958 · Cited by 450
Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Fujimoto, M., Grotendorst, G. R., & Takehara, K. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12345771 · Cited by 438
CTGF and SMADs, Maintenance of Scleroderma Phenotype Is Independent of SMAD Signaling
Holmes, A., Abraham, D. J., Sa, S., Shiwen, X., Black, C. M., & Leask, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010149200 · Cited by 423 · cited 5×
“nism (65, 92), is not suppressed by TNF- (97), sug-”
BackgroundResultInfluentialSelf-citationNuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
Horvai, A. E., Xu, L., Korzus, E., Brard, G., Kalafus, D., Mullen, T.-M., Rose, D. W., Rosenfeld, M. G., & Glass, C. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1074 · Cited by 422 · cited 1×
“Stat1 physically associates with p300 near its amino-terminal domain; this interaction plays an important functional role in positive regulation of IFN- -induced transcriptional responses (146, 147).”
BackgroundA mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA
Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., & Böttinger, E. P. (2000) · Genes & Development · doi:10.1101/gad.14.2.187 · Cited by 421
Chen, S.-J., Yuan, W., Mori, Y., Levenson, A., Varga, J., & Trojanowska, M. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00477.x · Cited by 410 · cited 5×
“For several years is has been known that TGF- induction of collagen occurs in an immediate-early fashion requiring the action of the Smads (63).”
BackgroundInfluentialProcessing of Transforming Growth Factor β1 Precursor by Human Furin Convertase
Dubois, C. M., Laprise, M.-H., Blanchette, F., Gentry, L. E., & Leduc, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10618 · Cited by 405 · cited 1×
“Due to this interaction, latent TGF- is incapable of binding to its receptors (21, 22).”
BackgroundWilborn, J., Crofford, L. J., Burdick, M. D., Kunkel, S. L., Strieter, R. M., & Peters-Golden, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117866 · Cited by 392 · cited 1×
“disorder (143, 144), suggesting the fibrosis may be”
BackgroundHayashida, T., de Caestecker, M., & Schnaper, H. W. (2003) · The FASEB Journal · doi:10.1096/fj.03-0037fje · Cited by 361
Role of Ras and Mapks in TGFβ signaling
Mulder, K. M. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00026-x · Cited by 348
Normal embryo fibroblasts release transforming growth factors in a latent form
Lawrence, D. A., Pircher, R., Krycève‐Martinerie, C., & Jullien, P. (1984) · Journal of Cellular Physiology · doi:10.1002/jcp.1041210123 · Cited by 327 · cited 5×
“TGF- is activated when LTBP is removed extracellularly via proteolytic cleavage (18; Fig.”
BackgroundInfluentialExpression of connective tissue growth factor in experimental rat and human liver fibrosis
Paradis, V., Dargere, D., Vidaud, M., de Gouville, A.-C., Huet, S., Martinez, V., Gauthier, J.-M., Ba, N., Sobesky, R., Ratziu, V., et al. (1999) · Hepatology · doi:10.1002/hep.510300425 · Cited by 324 · cited 1×
“In contrast to the situation in normal fibroblasts, CTGF is constitutively overexpressed in dermal fibrotic lesions such as in scleroderma (95, 97, 98), liver (99), renal (100, 101), lung (102), and pancreatic fibrosis (103).”
ResultDugina, V., Fontao, L., Chaponnier, C., Vasiliev, J., & Gabbiani, G. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.18.3285 · Cited by 314
Liver extracellular matrix in health and disease
Bedossa, P., & Paradis, V. (2003) · The Journal of Pathology · doi:10.1002/path.1397 · Cited by 308
Chen, C.-C., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008087200 · Cited by 305
Connective Tissue Growth Factor Gene Regulation
Leask, A., Holmes, A., Black, C. M., & Abraham, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210366200 · Cited by 305
Self-citationCoker, R. K., Laurent, G. J., Shahzeidi, S., Lympany, P. A., du Bois, R. M., Jeffery, P. K., & McAnulty, R. J. (1997) · Europe PMC (PubMed Central) · Cited by 292
Mice Lacking Smad3 Are Protected Against Cutaneous Injury Induced by Ionizing Radiation
Flanders, K. C., Sullivan, C. D., Fujii, M., Sowers, A., Anzano, M. A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J. B., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64926-7 · Cited by 285 · cited 1×
“After incisional wounding, animals lacking Smad3 show accelerated wound healing, reduced granulation tissue formation, increased epithelization, and reduced inflammation possibly due to an impaired chemotactic response (87) and resistance to cutaneous fibrosis caused by radiation injury (88).”
BackgroundKulkarni, A. B., & Karlsson, S. (1993) · PubMed · Cited by 283
Abraham, D. J., Shiwen, X., Black, C. M., Sa, S., Xu, Y., & Leask, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15220 · Cited by 255
Self-citationMORI, R., KONDO, T., OHSHIMA, T., ISHIDA, Y., & MUKAIDA, N. (2002) · The FASEB Journal · doi:10.1096/fj.01-0776com · Cited by 250 · cited 2×
“Mice lacking the TNF- receptor p55 show, after wounding, increased angiogenesis, collagen content, and re-epithelialization (129).”
BackgroundSaharinen, J., Taipale, J., & Keski-Oja, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00355.x · Cited by 239 · cited 5×
“TGF- is activated when LTBP is removed extracellularly via proteolytic cleavage (18; Fig.”
BackgroundInfluentialFibroblast-matrix interactions in wound healing and fibrosis
Eckes, B., Zigrino, P., Kessler, D., Holtkötter, O., Shephard, P., Mauch, C., & Krieg, T. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00077-9 · Cited by 238 · cited 1×
“Tissue fibrosis is generally considered to arise due to a failure of the normal wound healing response to terminate (1, 2).”
BackgroundStratton, R., Shiwen, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G. R., Black, C. M., & Abraham, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12020 · Cited by 232
Self-citationKane, C. J. M., Hebda, P. A., Mansbridge, J. N., & Hanawalt, P. C. (1991) · Journal of Cellular Physiology · doi:10.1002/jcp.1041480119 · Cited by 230 · cited 1×
“Upon cutaneous injury, TGF- is rapidly induced (70).”
BackgroundLigand-dependent Degradation of Smad3 by a Ubiquitin Ligase Complex of ROC1 and Associated Proteins
Fukuchi, M., Imamura, T., Chiba, T., Ebisawa, T., Kawabata, M., Tanaka, K., & Miyazono, K. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1431 · Cited by 226 · cited 1×
“degradation by the 26S proteosome (49).”
Ghosh, A. K., Yuan, W., Mori, Y., Chen, S.-J., & Varga, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004709200 · Cited by 225 · cited 2×
“Rather, in this cell type IFN- seems to suppress ECM synthesis by the ability of nuclear Stat1 to compete with the transcriptional cofactor p300 (14).”
BackgroundEvaluation of Anti-TGF-β2 Antibody as a New Postoperative Anti-scarring Agent in Glaucoma Surgery
Mead, A. L., Wong, T. T. L., Cordeiro, M. F., Anderson, I. K., & Khaw, P. T. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-0978 · Cited by 225 · cited 1×
“The use of TGF- as a target for antifibrotic intervention may be limited to acute situations, such as immediately after surgery (86), which would require application of the antifibrotic for a limited period.”
BackgroundRole of Endoglin in Cellular Responses to Transforming Growth Factor-β
Letamendı́a, A., Lastres, P., Botella, L. M., Raab, U., Langa, C., Velasco, B., Attisano, L., & Bernabeu, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33011 · Cited by 224
Activation of p21ras by transforming growth factor beta in epithelial cells.
Mulder, K. M., & Morris, S. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42722-6 · Cited by 223 · cited 1×
“In untransformed epithelial cells, mesangial cells, and fibroblasts, addition of TGF- results in a transient activation of the ras/MEK/ERK cascade (54, 55).”
BackgroundGuerrero-Esteo, M., Sánchez-Elsner, T., Letamendia, A., & Bernabéu, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111991200 · Cited by 219
Shen, X., Hu, P. P.-C., Liberati, N. T., Datto, M. B., Frederick, J. P., & Wang, X.-F. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3309 · Cited by 215 · cited 1×
“TGF- induction of gene expression often requires the transcriptional cofactor p300; the TGF- mediated phosphorylation of Smad3 potentiates the association between Smad3 and p300 (41).”
BackgroundConnective tissue growth factor: A new and important player in the pathogenesis of fibrosis
Leask, A., Holmes, A., & Abraham, D. J. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0009-x · Cited by 210
Self-citationCTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC
Chen, Y., Blom, I. E., Sa, S., Goldschmeding, R., Abraham, D. J., & Leask, A. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00567.x · Cited by 210
Self-citationConnective tissue growth factor in tubulointerstitial injury of diabetic nephropathy
Wang, S., Denichilo, M., Brubaker, C., & Hirschberg, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00776.x · Cited by 208 · cited 1×
“In contrast to the situation in normal fibroblasts, CTGF is constitutively overexpressed in dermal fibrotic lesions such as in scleroderma (95, 97, 98), liver (99), renal (100, 101), lung (102), and pancreatic fibrosis (103).”
ResultHierarchical model of gene regulation by transforming growth factor β
Yang, Y.-C., Piek, E., Zavadil, J., Liang, D., Xie, D., Heyer, J., Pavlidis, P., Kucherlapati, R., Roberts, A. B., & Böttinger, E. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834070100 · Cited by 205 · cited 1×
“However, as discussed above, Smad3 appears to be generally required in fibroblasts for the transcriptional response to TGF- (43).”
BackgroundSegarini, P. R., Nesbitt, J. E., Li, D., Hays, L. G., Yates, J. R., & Carmichael, D. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105180200 · Cited by 201
Brigstock, D. R., Steffen, C. L., Kim, G. Y., Vegunta, R. K., Diehl, J. R., & Harding, P. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20275 · Cited by 201
Dooley, S., Delvoux, B., Streckert, M., Bonzel, L., Stopa, M., ten Dijke, P., & Gressner, A. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02656-4 · Cited by 196
Chin, G. S., Liu, W., Peled, Z., Lee, T. Y., Steinbrech, D. S., Hsu, M., & Longaker, M. T. (2001) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-200108000-00022 · Cited by 196 · cited 1×
“Expression of TGF- and TGF- receptors are elevated in fibroblasts of human postburn hypertrophic scars, in keloids (benign, limited fibrotic skin lesions that result from an excessive wound healing response), and in keloid-derived fibroblasts (72, 73).”
BackgroundExpression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts
Mori, Y., Chen, S., & Varga, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11157 · Cited by 194 · cited 1×
“Although one report showed decreased levels of the inhibitory Smad7 in scleroderma fibroblasts (94), two other studies showed no difference in Smad7 levels between normal and scleroderma fibroblasts (65, 91); thus, Smad7 deficiency does not seem to be a general feature of scleroderma fibroblasts.”
ResultCyclooxygenases in the skin: pharmacological and toxicological implications
Lee, J. L., Mukhtar, H., Bickers, D. R., Kopelovich, L., & Athar, M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00301-6 · Cited by 189
Liu, C., Gaça, M. D. A., Swenson, E. S., Vellucci, V. F., Reiss, M., & Wells, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207728200 · Cited by 186
TGF-β1 activates MAP kinase in human mesangial cells: A possible role in collagen expression
Hayashida, T., Poncelet, A.-C., Hubchak, S. C., & Schnaper, H. W. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00733.x · Cited by 185
Actin cytoskeleton organization in response to integrin-mediated adhesion
Defilippi, P., Olivo, C., Venturino, M., Dolce, L., Silengo, L., & Tarone, G. (1999) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19991001)47:1<67::aid-jemt7>3.0.co;2-p · Cited by 183 · cited 1×
“The mechanical tension exerted by the myofibroblast is mediated through integrin-dependent signaling events including focal adhesion kinase, tyrosine kinase, and ERK activation (122, 123).”
BackgroundShi-wen, X., Pennington, D., Holmes, A., Leask, A., Bradham, D., Beauchamp, J. R., Fonseca, C., du Bois, R. M., Martin, G. R., Black, C. M., et al. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4972 · Cited by 180 · cited 4×
“CTGF promotes cell adhesion and migration in a wide variety of cell types (108–110) as well as collagen matrix contraction in fibroblasts (98).”
BackgroundResultInfluentialSelf-citationAllen, J. T., Knight, R. A., Bloor, C. A., & Spiteri, M. A. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.21.6.3719 · Cited by 180 · cited 1×
“In contrast to the situation in normal fibroblasts, CTGF is constitutively overexpressed in dermal fibrotic lesions such as in scleroderma (95, 97, 98), liver (99), renal (100, 101), lung (102), and pancreatic fibrosis (103).”
ResultBiology of TGF-β in knockout and transgenic mouse models
Böttinger, E. P., Letterio, J. J., & Roberts, A. B. (1997) · Kidney International · doi:10.1038/ki.1997.185 · Cited by 176
Scorza, R., Caronni, M., Mascagni, B., Berruti, V., Bazzi, S., Micallef, E., Arpaia, G., Sardina, M., Origgi, L., & VANOLI, M. (2001) · PubMed · Cited by 175
Frazier, W. A. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90052-z · Cited by 173
Cordeiro, M. F., Mead, A., Ali, R. R., Alexander, R. A., Murray, S., Chen, C., York-Defalco, C., Dean, N. M., Schultz, G. S., & Khaw, P. T. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301865 · Cited by 171 · cited 1×
“Incisional rat wounds, if treated with anti-TGF- antibodies or antisense oligonucleotides, suppress ECM synthesis and scarring (80, 81).”
BackgroundVerrecchia, F., Pessah, M., Atfi, A., & Mauviel, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005310200 · Cited by 170
Yue, J., & Mulder, K. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000039200 · Cited by 166
von Gersdorff, G., Susztak, K., Rezvani, F., Bitzer, M., Liang, D., & Böttinger, E. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11320 · Cited by 166
Lin, R. Y., Sullivan, K. M., Argenta, P. A., Meuli, M., Lorenz, H. P., & Adzick, N. S. (1995) · Annals of Surgery · doi:10.1097/00000658-199508000-00006 · Cited by 165 · cited 1×
“Supporting the notion that TGF- promotes fibrosis in vivo, treatment of fetal wounds with TGF- promotes wound closure and scarring (77, 78); TGF- induces excess matrix synthesis when injected subcutaneously in mice or into metal chambers implanted in the back of rats (78, 79).”
BackgroundTGF-β signaling from receptors to the nucleus
Roberts, A. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00258-0 · Cited by 161
Weston, B. S., Wahab, N. A., & Mason, R. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051600.53134.b9 · Cited by 161
Higashi, K., Inagaki, Y., Fujimori, K., Nakao, A., Kaneko, H., & Nakatsuka, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302339200 · Cited by 158
Schmid, P., Itin, P. H., Cherry, G., Bi, C., & Cox, D. (1998) · PubMed Central · Cited by 155
Diaz, A., Chepenik, K. P., Korn, J. H., Reginato, A. M., & Jimenez, S. A. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4050 · Cited by 152 · cited 11×
“TNF- has been proposed to suppress TGF- signaling via the NF- B induction of Smad7 (131), but this appears to be a cell type-specific effect and is not operative in dermal fibroblasts as TNF- does not induce Smad7 in this cell 821TGF- SIGNALING AND THE FIBROTIC RESPONSE type (132).”
InfluentialBetaglycan Inhibits TGF-β Signaling by Preventing Type I-Type II Receptor Complex Formation
Eickelberg, O., Centrella, M., Reiss, M., Kashgarian, M., & Wells, R. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105110200 · Cited by 149
Varga, J., & Jiménez, S. A. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(86)80591-5 · Cited by 146 · cited 8×
“Incisional rat wounds, if treated with anti-TGF- antibodies or antisense oligonucleotides, suppress ECM synthesis and scarring (80, 81).”
BackgroundInfluentialCrean, J. K. G., Finlay, D., Murphy, M., Moss, C., Godson, C., Martin, F., & Brady, H. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203715200 · Cited by 144
Stratton, R., Rajkumar, V., Ponticos, M., Nichols, B., Shiwen, X., Black, C. M., Abraham, D. J., & Leask, A. (2002) · The FASEB Journal · doi:10.1096/fj.02-0204fje · Cited by 143
Self-citationTyrosine phosphorylation and cytoskeletal tension regulate the release of fibroblast adhesions.
Crowley, E., & Horwitz, A. F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.2.525 · Cited by 143 · cited 1×
“The mechanical tension exerted by the myofibroblast is mediated through integrin-dependent signaling events including focal adhesion kinase, tyrosine kinase, and ERK activation (122, 123).”
BackgroundBlobe, G. C., Schiemann, W. P., Pepin, M.-C., Beauchemin, M., Moustakas, A., Lodish, H. F., & O'Connor-McCourt, M. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100188200 · Cited by 140
Gao, R., & Brigstock, D. R. (2003) · Hepatology Research · doi:10.1016/s1386-6346(03)00241-9 · Cited by 139
Leask, A., Denton, C. P., & Abraham, D. J. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2003.22133.x · Cited by 138
Self-citationTakagawa, S., Lakos, G., Mori, Y., Varga, J., Yamamoto, T., & Nishioka, K. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12308.x · Cited by 123
Altered Transforming Growth Factor β Signaling in Epithelial Cells when Ras Activation Is Blocked
Hartsough, M. T., Frey, R. S., Zipfel, P. A., Buard, A., Cook, S. J., McCormick, F., & Mulder, K. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22368 · Cited by 122 · cited 1×
“In untransformed epithelial cells, mesangial cells, and fibroblasts, addition of TGF- results in a transient activation of the ras/MEK/ERK cascade (54, 55).”
BackgroundSato, M., Shegogue, D., Gore, E. A., Smith, E. A., Trojanowska, M., & McDermott, P. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01719.x · Cited by 121
Blom, I. E., van Dijk, A. J., Wieten, L., Duran, K. J., Ito, Y., Kleij, L., DeNichilo, M. O., Rabelink, T. J., Weening, J. J., Aten, J., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.6.1139 · Cited by 118
McCartney-Francis, N. L., Frazier-Jessen, M., & Wahl, S. M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043009 · Cited by 116 · cited 4×
“The TGF- superfamily includes nearly 30 proteins in mammals including TGF- s, activins and inhibins, nodal, myostatin, bone morphogenetic proteins (BMPs), growth/differentiation factors (GDFs), and anti-Müllerian hormone (AMH, also called Müllerianinhibiting substance or MIS) (15, 16).”
BackgroundInfluentialHolmes, A., Abraham, D. J., Chen, Y., Denton, C., Shi-wen, X., Black, C. M., & Leask, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305019200 · Cited by 115 · cited 2×
“However, models examining stages of established fibrosis do not show such activation, which suggests that overexpression of profibrotic markers is Smad independent (65, 92, 93).”
BackgroundSelf-citationExpression of TGF-β1, -β2 and -β3 in localized and systemic scleroderma
Querfeld, C., Eckes, B., Huerkamp, C., Krieg, T., & Sollberg, S. (1999) · Journal of Dermatological Science · doi:10.1016/s0923-1811(99)00008-0 · Cited by 113
Leask, A., Abraham, D. J., Finlay, D. R., Holmes, A., Pennington, D., Shi‐Wen, X., Chen, Y., Venstrom, K., Dou, X., Ponticos, M., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10333 · Cited by 108
Self-citationMesangial Matrix Modulation and Glomerulosclerosis
Fogo, A. B. (1999) · Nephron Experimental Nephrology · doi:10.1159/000020595 · Cited by 103
Nishida, T., Kubota, S., Fukunaga, T., Kondo, S., Yosimichi, G., Nakanishi, T., Takano‐Yamamoto, T., & Takigawa, M. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10277 · Cited by 100
Verrecchia, F., Tacheau, C., Schorpp‐Kistner, M., Angel, P. E., & Mauviel, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204347 · Cited by 100 · cited 1×
“However, TGF- mediated induction of genes that do not require JNK/ c-jun, including a generic Smad3-responsive promoter, is antagonized by activation of JNK and overexpression of c-jun owing to the ability of c-jun and Smad3 to bind to each other, reducing the availability of free Smad3 (59, 69).”
BackgroundBall, D., Rachfal, A., Kemper, S., & Brigstock, D. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.176r001 · Cited by 96
Verrecchia, F., Tacheau, C., Wagner, E. F., & Mauviel, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206927200 · Cited by 89 · cited 1×
“The proinflammatory cytokine TNF- expressed by macrophages during the wound healing response (97) has long been known to possess antifibrotic ability in that it suppresses the expression of matrix genes (129) and the TGF- induction of collagen and CTGF (97, 130).”
BackgroundFAST-2 Is a Mammalian Winged-Helix Protein Which Mediates Transforming Growth Factor β Signals
Liu, B., Dou, C.-L., Prabhu, L., & Lai, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.424 · Cited by 88
Bettoni, L., Geri, A., Airó, P., Danieli, E., Cavazzana, I., Antonioli, C. M., Chiesa, L., Franceschini, F., Grottolo, A., Zambruni, A., et al. (2002) · Clinical Rheumatology · doi:10.1007/pl00011223 · Cited by 86
Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis
Díez-Marqués, L., Ortega-Velázquez, R., Langa, C., Rodríguez‐Barbero, A., López-Novoa, J. M., Lamas, S., & Bernabéu, C. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00051-0 · Cited by 85 · cited 1×
“In dermal fibrotic lesions of scleroderma patients, elevated TGF- levels are found at the leading edge of the forming scar tissue but not in the established lesions (74); similarly, fibrotic mesenchymal cells overexpress the TGF- ancillary endoglin that suppresses Smad3-dependent responses in cell culture (37, 75, 76).”
BackgroundPatterns of alternative splicing of fibronectin pre-mRNA in human adult and fetal tissues
Oyama, F., Murata, Y., Suganuma, N., Kimura, T., Titani, K., & Sekiguchi, K. (1989) · Biochemistry · doi:10.1021/bi00429a072 · Cited by 80 · cited 1×
“native splicing of the fibronectin transcript (9).”
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters
Maeda, T., Gupta, M. P., & Stewart, A. F. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00556-9 · Cited by 67 · cited 1×
“TEF family members have also been shown to be involved with tissue-specific expression of muscle proteins (96).”
BackgroundRoelen, B. A. J., Cohen, O. S., Raychowdhury, M. K., Chadee, D. N., Zhang, Y. E., Kyriakis, J. M., Alessandrini, A., & Lin, H. Y.-F. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00053.2003 · Cited by 66
LeRoy, E. C., Trojanowska, M., & Smith, E. A. (1990) · PubMed · Cited by 66
Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis
Petkova, D., Clelland, C., Ronan, J. E., Lewis, S., & Knox, A. J. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01718.x · Cited by 66 · cited 1×
“disorder (143, 144), suggesting the fibrosis may be”
BackgroundGillery, P., Serpier, H., Polette, M., Bellon, G., Clavel, C., Wegrowski, Y., Birembaut, P. L., Kalis, B., Cariou, R., & Maquart, F. (1992) · PubMed · Cited by 66
Riquet, F. B., Lai, W. T., Birkhead, J. R., Suen, L.-F., Karsenty, G., & Goldring, M. B. (2000) · Molecular Medicine · doi:10.1007/bf03402050 · Cited by 58
Rodríguez-Peña, A. B., Prieto, M., Düwel, A., Rivas, J. V., Eleno, N., Pérez‐Barriocanal, F., Arévalo, M. A., Smith, J. D., Vary, C., Bernabéu, C., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.34 · Cited by 56 · cited 1×
“In dermal fibrotic lesions of scleroderma patients, elevated TGF- levels are found at the leading edge of the forming scar tissue but not in the established lesions (74); similarly, fibrotic mesenchymal cells overexpress the TGF- ancillary endoglin that suppresses Smad3-dependent responses in cell culture (37, 75, 76).”
BackgroundEffects of anti-TGF-β type II receptor antibody on experimental glomerulonephritis
Kasuga, H., Ito, Y., Sakamoto, S., Kawachi, H., Shimizu, F., Yuzawa, Y., & Matsuo, S. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00990.x · Cited by 56
Saltzman, L. E., Moss, J., Berg, R. A., Hom, B., & Crystal, R. G. (1982) · Biochemical Journal · doi:10.1042/bj2040025 · Cited by 56
Ball, D., Moussad, E. E.-D. A., Rageh, M. A. E., Kemper, S., & Brigstock, D. R. (2003) · Reproduction · doi:10.1530/rep.0.1250271 · Cited by 53
Matsui, S., Takahashi, T., Oyanagi, Y., Takahashi, S., Boku, S., Takahashi, K., Furukawa, K., Arai, F., & Asakura, H. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80322-4 · Cited by 52
Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies
Assad, L., Schwartz, M. M., Virtanen, I., & Gould, V. E. (1993) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02899277 · Cited by 50
The 26S proteasome system in the signaling pathways of TGF-BETA superfamily
Wang, T. (2003) · Frontiers in Bioscience · doi:10.2741/1057 · Cited by 49
Initiators and Propagators of the Metabolic Response to Injury
Hill, A. G. (2000) · World Journal of Surgery · doi:10.1007/s002689910103 · Cited by 49 · cited 1×
“healing response (11), is antifibrotic in that this cyto-”
BackgroundStructure and activation of the large latent transforming growth factor-beta complex.
Nunes, I., Munger, J. S., Harpel, J. G., Nagano, Y., Rl, S., Gleizes, P., & Db, R. (1996) · PubMed · Cited by 48
Candela, M., Barker, S. C., & Ballou, L. R. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1363 · Cited by 45
Blockade of TGFβ3 up-regulation of p27Kip1 and p21Cip1 by expression of RasN17 in epithelial cells
Yue, J., Buard, A., & Mulder, K. M. (1998) · Oncogene · doi:10.1038/sj.onc.1201903 · Cited by 35 · cited 1×
“In all three cell types, ras/MEK/ERK is required for the ability of TGF- to induce expression of some proteins (56, 57).”
Backgrounddi Mola, F. F., Friess, H., Riesle, E., Koliopanos, A., Büchler, P., Zhu, Z., Brigstock, D. R., Korc, M., & Büchler, M. W. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00008 · Cited by 33 · cited 1×
“In contrast to the situation in normal fibroblasts, CTGF is constitutively overexpressed in dermal fibrotic lesions such as in scleroderma (95, 97, 98), liver (99), renal (100, 101), lung (102), and pancreatic fibrosis (103).”
Role of cytokines in controlling connective tissue gene expression
Hatamochi, A., Mori, K., & Ueki, H. (1994) · Archives of Dermatological Research · doi:10.1007/bf00370729 · Cited by 27 · cited 1×
“kine suppresses the expression of matrix genes (12).”
BackgroundStructure and activation of the large latent transforming growth factor-Beta complex.
Nunes, I., Munger, J. S., Harpel, J. G., Nagano, Y., Shapiro, R., Gleizes, P., & Db, R. (1998) · PubMed · Cited by 25
Miller, L. A., Barnett, N. L., Sheppard, D., & Hyde, D. M. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900105 · Cited by 21 · cited 1×
“A final activator of TGF- , the integrin v 6 , which is normally expressed at low levels only in epithelia (29), is induced during wounding or inflammation (29).”
BackgroundBalint, G. A. (1994) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80011-4 · Cited by 13
Guller, S. M., Wozniak, R., Leibman, M. I., & Lockwood, C. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21741.x · Cited by 10
Research works printed but not linked: 3
- 10.1111/j.1523-1755.2002.kid567.x · doi:10.1111/j.1523-1755.2002.kid567.x · Paper page
- Schmid P., 1998, Enhanced expression oftransforming growth factor-beta type and type II receptors in wound granulation tissue and hyper trophic scar, Am. J. Pathol., 152, 485
- 10.1111/j.1523-1755.1998.00820.x · doi:10.1111/j.1523-1755.1998.00820.x · Paper page
Cited by
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Gabrielli, A., Avvedimento, E. V., & Krieg, T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0806188 · Cited by 1,384
Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury
Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V., & Bonventre, J. V. (2010) · Nature Medicine · doi:10.1038/nm.2144 · Cited by 1,333
“TGF-β1 is a well-established principal driver of fibrosis via promotion of fibroblast proliferation, extracellular matrix synthesis and inhibition of collagenases in multiple organ”
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Metadata
- Authors
- Leask, A., & Abraham, D. J.
- Affiliations
- The Royal Free Hospital (GB)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-05
- Volume
- 18
- Issue
- 7
- Pages
- 816-827
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2122808924
- Cited by
- 2,319
- References
- 153
- Citations by year
- 2026: 53 · 2025: 53 · 2024: 63 · 2023: 79 · 2022: 75 · 2021: 103 · 2020: 99 · 2019: 113 · 2018: 145 · 2017: 174 · 2016: 163 · 2015: 179 · 2014: 141 · 2013: 134 · 2012: 115
- FWCI
- 6.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Scleroderma Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- TGF-beta signaling, fibrosis, fibrogenesis, extracellular matrix deposition, connective tissue growth factor, ED-A fibronectin, TNF-α, interferon-gamma
- MeSH terms
- Animals, DNA-Binding Proteins, Fibronectins, Fibrosis, Gene Expression Regulation, Humans, Interferon-gamma, Tumor Necrosis Factor-alpha, Wound Healing, Signal Transduction, Trans-Activators, Transforming Growth Factor beta, Extracellular Matrix Proteins, Immediate-Early Proteins, Receptors, Transforming Growth Factor beta, MAP Kinase Signaling System, Intercellular Signaling Peptides and Proteins, Smad3 Protein, Smad4 Protein, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.